CYP39A1 antibody
Principal name
CYP39A1 antibody
Alternative names for CYP39A1 antibody
Cytochrome P450 39A1, 24-hydroxycholesterol 7-alpha-hydroxylase, Oxysterol 7-alpha-hydroxylase
Ncbi ID
NP_057677.2, NP_057677, AAH10358, NM_016593, NP_061375.1, BC021418, BC037663, NM_018887
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of CYP39A1 antibody
- Kit Component:
- - KN304152G1, Cyp39a1 gRNA vector 1 in pCas-Guide vector
- KN304152G2, Cyp39a1 gRNA vector 2 in pCas-Guide vector
- KN304152D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Formalin-Fixed, Paraffin-Embedded Human Liver stained with CYP39A1 antibody Cat.-No AP31826PU-N
Immunofluorescence analysis of A549 cells, using CYP39A1 antibody Cat.-No AP31826PU-N. The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from LOVO/HuvEc cells, using CYP39A1 antibody Cat.-No AP31826PU-N. The lane on the right is treated with the synthesized peptide.
Immunohistochemical analysis of Cytochrome P450 39A1 staining in human liver cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of Cytochrome P450 39A1 expression in HeLa (A); HuvEc (B) whole cell lysates.
Immunohistochemical analysis of Cytochrome P450 39A1 staining in human lung cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of Cytochrome P450 39A1 expression in HeLa (A); HuvEc (B) whole cell lysates.
Western blot analysis of extracts from LOVO cells and HUVEC cells, using Cytochrome P450 39A1 antibody.The lane on the right is treated with the synthesized peptide.
Immunofluorescence analysis of A549 cells, using Cytochrome P450 39A1 antibody.The picture on the right is treated with the synthesized peptide.
Western blot analysis of extracts from 293/HeLa cells, using CYP39A1 antibody.The lane on the right is treated with the synthesized peptide.
Western Blot using mAb M30P6D6
CYP39A1 used in lymph node metastatic Colorectal cancer
CYP39A1 used in normal colon mucosa
Immunohistochemistry: wax-embedded human liver
CYP39A1 used in primary Colorectal cancer
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA315462 | CYP39A1 antibody |
||||||
| Rabbit polyclonal Cytochrome P450 39A1 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, ICC/IF, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA315463 | CYP39A1 antibody |
||||||
| Rabbit polyclonal anti-CYP39A1 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA349849 | CYP39A1 antibody |
||||||
| Rabbit Polyclonal Anti-CYP39A1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP31826PU-N | CYP39A1 (C-term) antibody |
||||||
 |
Rabbit | IgG | Aff - Purified | Hu, Ms | E, ICC/IF, P, WB |
50 µl /
€425.00
|
|
| OriGene Technologies GmbH | |||||||
| +2 additional images |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY413838 | CYP39A1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |